| |
|
|
|
|
|
 |
| |
|
¹Ù·Î°ÖÇöʾ×(¼öÃâ¿ë) VAROGEL SUSP. 20P[Aluminum hydroxide gel , Magnesium Hydroxide , Simethicone]
|
|
ÀϹÝÀǾàǰ | ºñ±Þ¿©
|
|
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
ÀϹÝ
|
|
|
|
| ¹ÚÇÏÇâÀÌ ³ª´Â ¹é»öÀÇ ÇöŹ¾× |
|
|
|
|
Á¦Á¶È¸»ç |
½ÅdzÁ¦¾à(ÁÖ)
|
ÆÇ¸Åȸ»ç |
½ÅdzÁ¦¾à(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2007.04.25)
|
BIT ¾àÈ¿ºÐ·ù |
Á¦»êÁ¦ & ÈíÂøÁ¦ (Antacids & Adsorbents)
|
º¹ÁöºÎºÐ·ù |
234[Á¦»êÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
648500890[A00304401] \0 ¿ø/10ml/1Æ÷(2002.04.25)(ÇöÀç¾à°¡)\0 ¿ø/10ml/1Æ÷(2002.04.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Antacids with antiflatulents / A02AF |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |

|
÷°¡Á¦ |
°¨ÃÊ¿¢½º,
¸»Æ®Çâ,
¹Ì°áÁ¤¼¿·ê·Î¿À½º¹×Ä«¸£º¹½Ã¸ÞÄ¥¼¿·ê·Î¿À½º³ªÆ®·ý,
¹ÚÇÏÇâ,
¿¡Åº¿Ã,
ÀÚÀϸ®Åç,
ÀÜź°Ë,
Á¤Á¦¼ö,
ÃÊ»êŬ·Î¸£Çí½Ãµò,
Æ÷ºñµ·,
È¿¼Ò󸮽ºÅ׺ñ¾Æ,
D-¼Ò¸£ºñÅç¿ë¾×
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦
ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î
·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
|
|
|
 | Çã°¡Á¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå »óÇÑ±Ý¾× |
648500890[A00304401]
[º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸]
\0 ¿ø/10ml/1Æ÷(2002.04.25)(ÇöÀç¾à°¡)
\0 ¿ø/10ml/1Æ÷(2002.04.01)(º¯°æÀü¾à°¡)
[»óº´ÄÚµåÁ¶È¸]
[Áúº´ÄÚµåÁý ´Ù¿î·Îµå]
[¿ì¸®Áý°Ç°ÁÖÄ¡ÀÇ ¹Ù·Î°¡±â]
|
| ºü¸¥Á¶È¸ |
|
| Á¦Ç°¼º»ó |
¹ÚÇÏÇâÀÌ ³ª´Â ¹é»öÀÇ Çöʾ×
[Á¦ÇüÁ¤º¸ È®ÀÎ]
|
| Æ÷À塤À¯Åë´ÜÀ§ |
ÀÚ»çÆ÷Àå´ÜÀ§¿¡ µû¸§ |
| Æ÷À塤ÄÚµå´ÜÀ§ |
| ¾àǰ±Ô°Ý |
´ÜÀ§ |
´ëÇ¥ÄÚµå |
Ç¥ÁØÄÚµå |
ºñ°í |
| 10¹Ð¸®¸®ÅÍ |
100 Æ÷ |
8806485008904 |
8806485008942 |
¼öÃâ¿ë |
| 10¹Ð¸®¸®ÅÍ |
20 Æ÷ |
8806485008904 |
8806485008935 |
¼öÃâ¿ë |
| 10¹Ð¸®¸®ÅÍ |
4 Æ÷ |
8806485008904 |
8806485008928 |
¼öÃâ¿ë |
| 10¹Ð¸®¸®ÅÍ |
1 Æ÷ |
8806485008904 |
8806485008911 |
¼öÃâ¿ë |
|
| ´ëÇ¥ÄÚµå |
8806485008904 |
| º¸°ü¹æ¹ý |
±â¹Ð¿ë±â, ¾óÁö ¾Êµµ·Ï ½Ç¿Â(1~30¡É)º¸°ü |
| È¿´ÉÈ¿°ú |
[ÀûÀÀÁõ º° °Ë»ö]
À§»ê°ú´Ù(À§¿°, À§¤ý½ÊÀÌÁöÀå±Ë¾ç¿¡ °ü·ÃµÈ °Íµµ Æ÷ÇÔ), ¼Ó¾²¸²,
À§ºÎºÒÄè°¨, À§ºÎÆØ¸¸°¨, ½Äü(À§Ã¼), ±¸¿ª, ±¸Åä, À§Åë, ½ÅÆ®¸²,
°¡½ºÁ¦°Å
|
| ¿ë¹ý¿ë·® |
* Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù.
[󹿾à¾î]
¼ºÀÎ 1ȸ 1Æ÷(10ml) 1ÀÏ 4ȸ ½Ä°£ ¹× Ãëħ½Ã¿¡ º¹¿ëÇÑ´Ù.
|
| ±Ý±â |
Åׯ®¶ó½ÎÀÌŬ¸°·ùÀÇ Ç×»ýÁ¦¸¦ Åõ¿©¹Þ°í Àִ ȯÀÚ
2. ´ÙÀ½ ȯÀÚ¿¡´Â ½ÅÁßÈ÷ Åõ¿©ÇÒ °Í
½ÅºÎÀü ȯÀÚ
<´ÙÀ½ ȯÀÚ¿¡´Â Åõ¿©ÇÏÁö ¸»°Í>
(1) ¼Ò¾ÆÀÇ ¼ÕÀÌ ´êÁö ¶ó´Â °÷¿¡ º¸°üÇÒ°Í
(2) Á÷»ç±¤¼±À» ÇÇÂ÷°í µÇµµ·ÏÀ̸é (½À±â°¡ ÀûÀº) ¼´ÃÇÑ °÷¿¡ (¹ÐÀüÇÏ¿©) º¸°üÇÒ°Í
(3) ¿À¿ëÀ» ¸·°í ǰÁúÀÇ º¸Á¸À» À§ÇÏ¿© ´Ù¸¥¿ë±â¿¡ ¹Ù²Ù¾î ³ÖÁö ¸»°Í
(Àǰü656223-819È£ 2003. 4.22)
<´ÙÀ½ ȯÀÚ¿¡´Â Åõ¿©ÇÏÁö ¸»°Í>
Åõ¼®¿ä¹ýÀ» ¹Þ°í Àִ ȯÀÚ
2. ÀϹÝÀû ÁÖÀÇ
1) Àå±â¿¬¿ëÀ» ÇÏÁö ¾Ê´Â´Ù.
½ÅÀ庴ÀÇ º´·ÂÀÌ Àִ ȯÀÚ´Â º¹¿ëÀü¿¡ ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »óÀÇÇÑ´Ù.
|
| ½ÅÁßÅõ¿© |
´Ù¸¥ ¾à¹°À» ·ç¿©¹Þ°í Àִ ȯÀÚ
|
| ÀÌ»ó¹ÝÀÀ |
(1) 2ÁÖÁ¤µµ º¹¿ëÇÏ¿©µµ Áõ»óÀÇ °³¼±ÀÌ ¾øÀ» ¶§¿¡´Â º¹¿ëÀ» ÁßÁöÇÏ°í ¾à»ç ¶Ç´Â ÀÇ»ç¿Í »óÀÇ ÇÒ°Í
(2) ÀÇ»çÀÇ Ã³¹æ¾øÀÌ 1ÀÏ 60¹Ð¸®¸®ÅÍ ÀÌ»ì º¹¿ëÇÏÁö ¾Êµµ·Ï ÇÑ´Ù.
|
| Àû¿ë»óÀÇ ÁÖÀÇ |
(1) Á¤ÇØÁø ¿ë¹ý¿ë·® À» Àß Áö ų°Í
(2) À̾àÀº 3°³¿ù ¹Ì¸¸ÀÇ À¯¾Æ¿¡°Ô´Â º¹¿ë½ÃŰÁö ¸»°Í
|
| º¸°ü ¹× Ãë±Þ»óÀÇ ÁÖÀÇ |
(1) ¼Ò¾ÆÀÇ ¼ÕÀÌ ´êÁö ¶ó´Â °÷¿¡ º¸°üÇÒ°Í
(2) Á÷»ç±¤¼±À» ÇÇÂ÷°í µÇµµ·ÏÀ̸é (½À±â°¡ ÀûÀº) ¼´ÃÇÑ °÷¿¡ (¹ÐÀüÇÏ¿©) º¸°üÇÒ°Í
(3) ¿À¿ëÀ» ¸·°í ǰÁúÀÇ º¸Á¸À» À§ÇÏ¿© ´Ù¸¥¿ë±â¿¡ ¹Ù²Ù¾î ³ÖÁö ¸»°Í
(Àǰü656223-819È£ 2003. 4.22)
|
| Related FDA Approved Drug |
|
|
|
 | Á¤º¸¿ä¾à |
|
|
|
µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
|
|
 | ÄÚµå ¹× ºÐ·ùÁ¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
| ¼ººÐÄÚµå |
M081053/¼ö»êȸ¶±×³×½·30%ÆäÀ̽ºÆ® 26.68±×·¥ /
M234803/¼ö»êȾ˷ç¹Ì´½ °Ö 45.96±×·¥ /
M081054/½Ã¸ÞÄ¡ÄÜ30%¿¡¸ÖÁ¯ 2.66±×·¥ /
|
| ´ëÇ¥ÄÚµå |
8806485008904 |
| BIT ¾àÈ¿ºÐ·ù |
Á¦»êÁ¦ & ÈíÂøÁ¦ (Antacids & Adsorbents)
|
| ATC ÄÚµå |
Antacids with antiflatulents / A02AF
[ÄÚµåºÐ·ù»ó¼¼¼³¸í]
[ATCÄÚµå¿¹Ãø]
|
| º¹ÁöºÎºÐ·ùÄÚµå |
234 (Á¦»êÁ¦ )
|
| ÀǾàǰ ¹ÙÄÚµåÁ¤º¸ |
³»¿ëº¸±â
¹Ù·Î°ÖÇöʾ×(¼öÃâ¿ë)/ A00304401
Á¦Ç°±Ô°Ý: /Á¦Ç°¼ö·®: 4/Á¦Çü: Æ÷
Æû¸ñ±âÁØÄÚµå: 200704808 /´ëÇ¥ÄÚµå: 8806485008904/Ç¥ÁØÄÚµå: 8806485008928
±¸¹ÙÄÚµå: 8806103827054/ºñ°í:-
¹Ù·Î°ÖÇöʾ×(¼öÃâ¿ë)/ A00304401
Á¦Ç°±Ô°Ý: /Á¦Ç°¼ö·®: 20/Á¦Çü: Æ÷
Æû¸ñ±âÁØÄÚµå: 200704808 /´ëÇ¥ÄÚµå: 8806485008904/Ç¥ÁØÄÚµå: 8806485008935
±¸¹ÙÄÚµå: 8806103827061/ºñ°í:-
¹Ù·Î°ÖÇöʾ×(¼öÃâ¿ë)/ A00304401
Á¦Ç°±Ô°Ý: /Á¦Ç°¼ö·®: 100/Á¦Çü: Æ÷
Æû¸ñ±âÁØÄÚµå: 200704808 /´ëÇ¥ÄÚµå: 8806485008904/Ç¥ÁØÄÚµå: 8806485008942
±¸¹ÙÄÚµå: -/ºñ°í:-
|
ÁÖ¼ººÐÄÚµå ºÐ¼® ¹× Áߺ¹Ã³¹æ °ËÅä |
[ÁÖ¼ººÐÄÚµå ºÐ¼® ¹× Áߺ¹Ã³¹æ °ËÅä]
|
| Drugs By Indication |
[Àüüº¸±â]
|
| Drugs By Classification |
[Àüüº¸±â]
|
|
|
 | Á¦Ç°Á¤º¸ |
|
|
|
|
 | º¹¾àÁ¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
| LACTmed ¹Ù·Î°¡±â |
[¹Ù·Î°¡±â]
|
| Ãà¾àº¹¾àÁöµµ |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| º¹¾àÁöµµ |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| ÀӺο¡´ëÇÑÅõ¿© |
| * |
ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù.
|
|
|   |
 FDA : Cµî±Þ
(simethicone )
|
|
| * |
»ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
|
| * |
¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
|
|
|
| Pharmacokinetics |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| º¸°ü»ó ÁÖÀÇ |
|
| Á¶Á¦½Ã ÁÖÀÇ |
|
|
|
 | ½É»çÁ¤º¸ |
|
|
|
|
 | ÇмúÁ¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
| DUR (ÀǾàǰ»ç¿ëÆò°¡) |
º´¿ë±Ý±â :
°í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]
¿¬·É´ë±Ý±â :
°í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
|
| µ¶¼ºÁ¤º¸ |
Magnesium¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â
Ãâó: ±¹¸³µ¶¼º°úÇпø µ¶¼º¹°ÁúÁ¤º¸DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do |
| Pharmacokinetics |
SimethiconeÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
- ¼Ò½Ç : ¹Ìº¯Èü·Î º¯¹è¼³µÈ´Ù.
Aluminum hydroxide gelÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
- ÀÛ¿ë¹ßÇö½Ã°£ : 10-15 ºÐ
- ÀÛ¿ëÁö¼Ó½Ã°£ : °øº¹½Ã : 30 ¡¾ 10 ºÐ
½ÄÈÄ 1½Ã°£ Åõ¿©½Ã : 1-3 ½Ã°£
- Èí¼ö : ½ÅºÎÀüÀÇ °æ¿ì Èí¼öµÇ¾î Ç÷Áß aluminum ³óµµ°¡ Áõ°¡µÉ ¼ö ÀÖ´Ù.
Magnesium HydroxideÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
- Èí¼ö : °øÀå, ȸÀå¿¡¼ ´Éµ¿, ¼öµ¿ Èí¼ö
- »çÇÏÀÛ¿ë ¹ßÇö : 4-8 ½Ã°£
- ¼Ò½Ç : Èí¼öµÈ ¸¶±×³×½·Àº ½Å¼ÓÇÏ°Ô ½ÅÀå ¹è¼³, Èí¼öµÇÁö ¾ÊÀº ¸¶±×³×½·Àº ´ëº¯ ¹è¼³
|
CYP450 Drug Interaction |
[CYP450 TableÁ÷Á¢Á¶È¸]
|
|
|
 | »ç¿ëÀÚÄÁÅÙÃ÷ |
|
|
|
|
|
-
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2025-11-03
-
º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
|
|
¾Ë¸² |
»ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù. |
|
°æ°í |
µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù.
Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â
Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
|
|
¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é
¿©±â·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
|
|
|
|